Charles River Labs to lay off nearly 300 workers in Shrewsbury
January 11, 2010 by MassDevice staff
Wilmington, Mass.-based CRO Charles River Laboratories International plans to shutter its Shrewsbury, Mass., facility by the middle of 2010 and expects to take $7 million in restructuring charges during the first quarter as it sheds nearly 300 positions.
Charles River Laboratories International Inc. (NYSE:CRL) suspended operations at its preclinical services unit in Shrewsbury, a move that will result in about 300 layoffs.
About 30 of the 300 employees will be kept on to maintain the facility or be reassigned to other positions within the company, according to a spokeswoman for the Wilmington, Mass.-based contract research organization. Operations will resume at the facility when "global preclinical market conditions improve and the Company requires additional capacity," according to a press release.
The preclinical unit provides the services required to take a drug through the development process, including discovery support, toxicology, pathology, as well as Phase I clinical trials, according to the company.
- Show full page
- Login to post comments
-
Permalink
FDA Database Search
RECENT BLOG POSTS
- Funding R&D: High prices, overuse a failed strategy
- FDA's role in promoting women's health
- New partnership to boost use of GMDN codes for medical devices
- FDA's modern "Corps of Discovery" in China
- Consumers lose in latest FDA user fee bill; COI restraints disappear
- Gamification
- Cool technology of the week
- A new day: Interim thoughts on the 2012 Heart Rhythm Society scientific sessions
- When a child loses milestones, consider sleep EEG studies
- Red or blue pill for payment reform? Both won't work
NEWS
EuroPCR: Warnings on TAVI in replacing surgically implanted prosthetic valves
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
Weight loss: Surgery triggers rare metabolic wasting disease | MassDevice.com On Call
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Medical device tax: Ohio's industry pushes repeal while GOP group gets hyper-political
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
MassDevice.com +3 | The top 3 med-tech stories for May 15, 2012.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed CEO Robert Hansen retires after 20 years at the helm | Personnel Moves
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
